RINVOQ COMPLETE Trademark

Trademark Overview


On Friday, April 8, 2022, a trademark application was filed for RINVOQ COMPLETE with the United States Patent and Trademark Office. The USPTO has given the RINVOQ COMPLETE trademark a serial number of 97354444. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, March 6, 2023. This trademark is owned by AbbVie Biotechnology Ltd. The RINVOQ COMPLETE trademark is filed in the Education & Entertainment Services and Computer & Software Services & Scientific Services categories with the following description:

Providing a website featuring nondownloadable publications in the nature of brochures, articles and newsletters in the field of health; Educational services, namely, training in the field of immunology, auto-immune diseases, dermatology, rheumatology, gastroenterology and treatments thereof

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing scientific information in the field of immunology, auto-immune diseases, dermatology, rheumatology, gastroenterology and treatments thereof via the internet, digital media and data banks; Providing scientific research information concerning clinical study results and clinical study data by means of interactive web sites
rinvoq complete

General Information


Serial Number97354444
Word MarkRINVOQ COMPLETE
Filing DateFriday, April 8, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, March 6, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesProviding a website featuring nondownloadable publications in the nature of brochures, articles and newsletters in the field of health; Educational services, namely, training in the field of immunology, auto-immune diseases, dermatology, rheumatology, gastroenterology and treatments thereof
Goods and ServicesProviding medical and scientific research information in the field of pharmaceuticals and clinical trials; providing scientific information in the field of immunology, auto-immune diseases, dermatology, rheumatology, gastroenterology and treatments thereof via the internet, digital media and data banks; Providing scientific research information concerning clinical study results and clinical study data by means of interactive web sites

Classification Information


International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateWednesday, April 13, 2022
Primary Code041
First Use Anywhere DateTuesday, December 17, 2019
First Use In Commerce DateTuesday, December 17, 2019

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 13, 2022
Primary Code042
First Use Anywhere DateTuesday, December 17, 2019
First Use In Commerce DateTuesday, December 17, 2019

Trademark Owner History


Party NameAbbVie Biotechnology Ltd
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHamilton, Pembroke HM11
BM

Trademark Events


Event DateEvent Description
Monday, March 6, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, March 6, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, March 6, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, August 22, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, August 22, 2022FINAL REFUSAL E-MAILED
Monday, August 22, 2022FINAL REFUSAL WRITTEN
Thursday, August 4, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 4, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 4, 2022ASSIGNED TO LIE
Wednesday, July 13, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 1, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 1, 2022NON-FINAL ACTION E-MAILED
Friday, July 1, 2022NON-FINAL ACTION WRITTEN
Monday, June 27, 2022ASSIGNED TO EXAMINER
Wednesday, April 13, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 12, 2022NEW APPLICATION ENTERED